Causal AI-based clinical and radiomic analysis for optimizing patient selection in combined immunotherapy and SABR in early-stage NSCLC: a secondary analysis of the phase II I-SABR trial

Combining clinical and radiomic parameters, I-SABR-SELECT uses causal reasoning to individualize treatment selection for patients with early-stage inoperable NSCLC. If validated, it could serve as a foundation for a treatment-focused digital twin by integrating real-time adaptive decision-making. <b>Code:</b> https://github.com/WuLabMDA/ISABR-SELECT.

Authors

Institutions

Publication Details

Journal
Journal for ImmunoTherapy of Cancer
Published
2025-10-01
DOI
https://doi.org/10.1136/jitc-2025-013074
Citations
1
Primary Topic
Radiomics and Machine Learning in Medical Imaging
Type
article
Field-Weighted Citation Impact
1.36

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Causal AI-based clinical and radiomic analysis for optimizing patient selection in combined immunotherapy and SABR in early-stage NSCLC: a secondary analysis of the phase II I-SABR trial

Jia Wu, David A. Jaffray, Joe Y. Chang, Vivek Verma et al.
1 citations
Journal for ImmunoTherapy of Cancer
Radiomics and Machine Learning in Medical Imaging
1.36
article

Causal AI-based clinical and radiomic analysis for optimizing patient selection in combined immunotherapy and SABR in early-stage NSCLC: a secondary analysis of the phase II I-SABR trial

Jia Wu, David A. Jaffray, Joe Y. Chang, Vivek Verma, M. Qayati Mohamed, Morteza Salehjahromi, Maliazurina B. Saad, John Victor Heymach, Muhammad Aminu, Eman Showkatian, Yuliya Kitsel, Sheeba J. Sujit, Qasem Al-Tashi, Steven Hsesheng Lin, David C. Qian, Caroline Chung, Natalie I. Vokes, Jianjun Zhang, J. Jack Lee, Zhongxing Liao, Saumil Gandhi, Xinyan Xu
article en
1 citations

Abstract

Combining clinical and radiomic parameters, I-SABR-SELECT uses causal reasoning to individualize treatment selection for patients with early-stage inoperable NSCLC. If validated, it could serve as a foundation for a treatment-focused digital twin by integrating real-time adaptive decision-making. <b>Code:</b> https://github.com/WuLabMDA/ISABR-SELECT.

Journal for ImmunoTherapy of CancerVol. 13(10)
The University of Texas MD Anderson Cancer Center (US)
Bristol-Myers Squibb, National Institutes of Health, University of Texas MD Anderson Cancer Center, National Cancer Institute
Openalex Percentile: Top 15%
Radiomics and Machine Learning in Medical Imaging
1.36
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.